News | November 06, 2009

First Transcatheter Valve Cases in Japan Performed With Edwards Sapien Valve

November 6, 2009 – Edwards Lifesciences Corp. today announced the first successful Japanese implants of a transcatheter aortic heart valve using its Edwards SAPIEN valve.

The transfemoral and transapical valve implantations were performed by Osaka University last month in preparation for Osaka’s Senshin-Iryo application submission to the Japanese Ministry of Health, Labour and Welfare.

“We are continuing the momentum of Edwards’ global transcatheter heart valve program with the first human implants in Japan. We look forward to providing this important treatment option to more Japanese patients and continuing to demonstrate very strong patient outcomes with the Edwards SAPIEN valve,” said Michael A. Mussallem, Edwards’ chairman and CEO.

The Edwards SAPIEN valve was approved for sale in Europe in late 2007. It has been used in the treatment of thousands of high-risk patients in both commercial and clinical trial environments, and evaluated as part of nine rigorous scientific studies now complete or underway. In the United States, it is being studied as part of the world’s only randomized, pivotal clinical trial of a transcatheter aortic valve.

For more information: www.edwards.com

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Sponsored Content | Videos | Heart Valve Technology| August 30, 2017
Azeem Latib, M.D., MBBCh, FCP, interventional cardiologist at Columbus Hospital in Milan, Italy, discusses the latest
PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
CMS Awards New Technology Add-on Payment for Perceval Sutureless Aortic Heart Valve
News | Heart Valve Technology| August 22, 2017
August 22, 2017 — LivaNova PLC announced its Perceval ...
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init